Abstract
We compared the use of cough and cold medications in 2 multicenter studies of young children hospitalized with bronchiolitis before and after the 2008 Food and Drug Administration cough and cold medications advisory. Although cough and cold medication use decreased after the advisory, nearly 20% of children age 12-23.9 months with severe bronchiolitis received cough and cold medications.
Copyright © 2015 Elsevier Inc. All rights reserved.
Publication types
-
Multicenter Study
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Age Factors
-
Antitussive Agents / administration & dosage
-
Antitussive Agents / adverse effects
-
Bronchiolitis / drug therapy*
-
Common Cold / drug therapy*
-
Cough / drug therapy*
-
Expectorants / administration & dosage
-
Expectorants / adverse effects
-
Female
-
Humans
-
Infant
-
Male
-
Mothers
-
Nasal Decongestants / administration & dosage
-
Nasal Decongestants / adverse effects
-
Nonprescription Drugs / administration & dosage*
-
Nonprescription Drugs / adverse effects*
-
Prospective Studies
-
Safety-Based Drug Withdrawals
-
Severity of Illness Index
-
Smoking / epidemiology
-
United States
-
United States Food and Drug Administration
Substances
-
Antitussive Agents
-
Expectorants
-
Nasal Decongestants
-
Nonprescription Drugs